Two Sigma Investments
LEXX icon

Two Sigma Investments’s Lexaria Bioscience LEXX Stock Holding History

Two Sigma Investments’s Portfolio LEXX Stock Details LEXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-13,063
Closed -$32K – 2950
2022
Q3 		$32K Sell
13,063
-4,338
-25% -$12.4K ﹤0.01% 2351
2022
Q2 		$52K Buy
+17,401
New +$46.6K ﹤0.01% 2342

Other funds holding LEXX

ICM
Invenomic Capital Management Boston, Massachusetts $2.18B AUM 0.03% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
CC
Centiva Capital New York $13.6B AUM 20% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
1832 Asset Management
1832 Asset Management Toronto, Ontario, Canada $109B AUM 35.56% 1-Year Est. Return

Two Sigma Investments's LEXX Position: Q4 2022 in Review

Two Sigma Investments sold out of Lexaria Bioscience (LEXX) in Q4 2022, closing a stake of 13,063 shares — an estimated $32K sold.

Two Sigma Investments first reported a position in LEXX in Q2 2022 and held it in 2 quarters. The position peaked at $52K in Q2 2022. 16 funds tracked by Wall St. Rank hold LEXX as of Q4 2022.

  • Two Sigma Investments reported no remaining Lexaria Bioscience position as of Q4 2022 after selling out during the quarter.
  • Two Sigma Investments sold 13,063 Lexaria Bioscience shares in Q4 2022, an estimated $32K.
  • Two Sigma Investments first reported a position in Lexaria Bioscience in Q2 2022 and held it in 2 quarters.
  • Two Sigma Investments's Lexaria Bioscience position peaked at $52K in Q2 2022.
  • 16 funds tracked by Wall St. Rank held Lexaria Bioscience as of Q4 2022.

Based on Two Sigma Investments's 13F filing for Q4 2022, filed 14 Feb 2023.